Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
The patient received Arexvy on 9/11/2023 but no one entered it into Immunization Registry. We were performing an employee vaccine clinic and was working off immunization registry to identify what vaccines were due. Immunization registry indicated patient was due for RSV. We administered vaccine. We were notified from our corporate office that patient already received vaccine in 2023. Patient was not experiencing any side effects but wanted to report the double dose.